Sabre Corpo (SABR)

Featured in Small-Cap Stocks

Sabre Corporation is a common stock listing on the NASDAQ exchange. The company operates as a software and technology provider focused on the travel industry, with activities spanning the United States, Europe, Asia-Pacific, and other international markets. Its portfolio includes the Sabre Mosaic marketplace, a business-to-business platform connecting travel suppliers and buyers, along with technology products and solutions for airlines and other travel providers. These offerings include reservation systems for full-service and low-cost carriers, commercial and operations tools, agency solutions, and data-driven intelligence products. Sabre also provides SabreMosaic Airline Technology, an offer-and-order retailing platform for airlines. The company serves airlines, hotels, car rental brands, rail carriers, cruise lines, tour operators, attractions and related services, as well as travel agencies, travel management companies, corporate travel departments, airports, governments, and tourism boards. Sabre was founded in 1960 and is headquartered in Southlake, Texas.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-SABR
$2.13
24.0% Upside
Undervalued
$1.99
16.1% Upside
Fair
Fair
0.0%
August 4, 2026
-2.8x
-0.7x
0.2x
679.9 M
4.328 B
85.8%
66.3%
-0.7
112.6%
Valuation • Fair Value

Sabre Corpo (NASDAQ-SABR) Fair Value by Valuation Model

Compare the primary fair value estimate for Sabre Corpo (NASDAQ-SABR) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$2.13

Estimated upside of 24.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.78

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$2.41

Comparable-company valuation reference.

Analyst Price Target

$1.99

Analysts imply upside of 16.1%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Sabre Corpo (NASDAQ-SABR) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Sabre Corpo (NASDAQ-SABR)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.829 B

Current operating scale indicator.

Revenue Forecast

2.886 B

Forward revenue estimate.

EBITDA

413.1 M

Current operating profitability reference.

EBITDA Forecast

573.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Sabre Corpo (NASDAQ-SABR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Sabre Corpo (NASDAQ-SABR)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.58

No elevated caution signal from this screen.

Altman Z-Score

-0.7

Lower score that deserves closer risk review.

FCF / Net Income

112.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Sabre Corpo (NASDAQ-SABR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Sabre Corpo (NASDAQ-SABR)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Sabre Corpo (NASDAQ-SABR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Sabre Corpo (NASDAQ-SABR) Stock Forecast & Technical Outlook

Review Sabre Corpo (NASDAQ-SABR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Sabre Corpo (NASDAQ-SABR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Sabre Corpo (NASDAQ-SABR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Sabre Corpo (NASDAQ-SABR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Sabre Corpo (NASDAQ-SABR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Sabre Corpo (NASDAQ-SABR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Sabre Corpo (NASDAQ-SABR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Sabre Corpo (NASDAQ-SABR) has a Hold consensus, with 1 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 6
Sell 0
FAQ Fast Investor Answers

Sabre Corpo (NASDAQ-SABR) Stock FAQ

Quick answers about Sabre Corpo (NASDAQ-SABR) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$2.13
Estimated upside 24.0%
Valuation Rating
Undervalued
Estimated upside of 24.0%
Analyst Target
$1.99
Implied upside 16.1%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Sabre Corpo (NASDAQ-SABR) is $2.13. This implies an estimated upside of 24.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 24.0% versus the current market price.

The available analyst price target for Sabre Corpo (NASDAQ-SABR) is $1.99. The analyst target implies estimated upside of 16.1%.

The current financial health read for Sabre Corpo (NASDAQ-SABR) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Sabre Corpo (NASDAQ-SABR) is August 4, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Sabre Corpo (NASDAQ-SABR) is -2.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Sabre Corpo is 679.9 M.

The current enterprise value listed for Sabre Corpo is 4.328 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Sabre Corpo is NASDAQ-SABR, and the stock is listed on NASDAQ.

Sabre Corpo (NASDAQ-SABR) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Sabre Corpo is 85.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Sabre Corpo is 66.3%. Free float helps investors understand how much of the share base is available for public trading.